JPRN-UMIN000007001
已完成
未知
Alternating Chemotherapy and Radiotherapy in Advanced Laryngeal Cancers - Alternating Chemotherapy and Radiotherapy in Advanced Laryngeal Cancers
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- aryngeal cancer
- 发起方
- Aichi Cancer Center
- 入组人数
- 26
- 状态
- 已完成
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\)Previously treated patients 2\)A history of radiation therapy 3\)Serious complication 4\)A history of cerebral infarction
结局指标
主要结局
未指定
相似试验
已完成
不适用
Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancerlocally advenced tongue cancerJPRN-UMIN000032732Department of radiation oncology, Southern Tohoku Proton Therapy Center30
尚未招募
2 期
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with limited metastatic disease - TNT-OES-1 TRIANL-OMON49762Erasmus MC, Universitair Medisch Centrum Rotterdam20
招募中
不适用
Combination of chemoTherapy aNd chemoradioTherapy for adenocarcinoma of the OESophagus and gastro-oesophageal junction with oligometastatic diseaseNL-OMON23939Erasmus MC20
进行中（未招募）
1 期
Chemotherapy followed by chemoradiotherapy for metastatic esophageal cancerPatients (18 – 75 years) who are diagnosed with adenocarcinoma of the oesophagus or GOJ with a resectable primary tumour and de-novo synchronous oligometastatic disease.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-003605-55-NLErasmus MC - University Medical Centre20
进行中（未招募）
不适用
ow-doses radiotherapy and concomitant chemotherapy with pemetrexed in progression desease NSCLC: a dose-descalation phase II study - NDadvanced and/or metastatic NSCLCMedDRA version: 9.1Level: LLTClassification code 10059515Term: Non-small cell lung cancer metastaticEUCTR2008-003690-40-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI